Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24119556 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sarmed Al-Samerria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Growth and Reproductive Development, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers, The State University …. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Human Growth Hormone. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institute for Health Care Management Foundation.
Abstract (Originalsprache)
Obesity is a growing public health problem worldwide, and GH and IGF-1 have been studied as potential therapeutic targets for managing this condition. This review article aims to provide a comprehensive view of the interplay between GH and IGF-1 and metabolism within the context of obesity. We conducted a systematic review of the literature that was published from 1993 to 2023, using MEDLINE, Embase, and Cochrane databases. We included studies that investigated the effects of GH and IGF-1 on adipose tissue metabolism, energy balance, and weight regulation in humans and animals. Our review highlights the physiological functions of GH and IGF-1 in adipose tissue metabolism, including lipolysis and adipogenesis. We also discuss the potential mechanisms underlying the effects of these hormones on energy balance, such as their influence on insulin sensitivity and appetite regulation. Additionally, we summarize the current evidence regarding the efficacy and safety of GH and IGF-1 as therapeutic targets for managing obesity, including in pharmacological interventions and hormone replacement therapy. Finally, we address the challenges and limitations of targeting GH and IGF-1 in obesity management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Growth and Reproductive Development, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
ORCID-Profile: Sarmed Al-Samerria
Förderung
- NICHD NIH HHS
- National Institute for Health Care Management Foundation
Zitieren
APA
Al-Samerria, S., & Radovick, S. (2023). Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119556
Vancouver
Al-Samerria S, Radovick S. Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119556
BibTeX
@article{AlSamerria2023,
author = {Al-Samerria, Sarmed and Radovick, Sally},
title = {Exploring the Therapeutic Potential of Targeting GH and IGF-1 in the Management of Obesity: Insights from the Interplay between These Hormones and Metabolism},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24119556}
}
EUVIMED